Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

TAVR still a safe treatment option for immunocompromised patients
While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.
Pope welcomes cardiologists to Vatican City
Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart “both physically and metaphorically, bringing relief to those who suffer.”
Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR
The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public
The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.
Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.

Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health, a collaboration between Ascension Texas and the University of Texas at Austin, including its Dell Medical School. This new, state-of-the-art cardiology program fully integrates all the cardiac subspecialties to create a comprehensive heart team approach in treating patients.

VIDEO: Creating an integrated heart team program in central Texas

Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health in Austin, Texas, discusses the facility's new, state-of-the-art cardiology program.

Links to all the SCAI 2022 late-breaking clinical research

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions.

There has been fear of a small number of patient who experience myocarditis after COVID vaccination, but a new study found it is safe in patients with prior heart damage. Image courtesy of Banner Health. #COVID19 #COVIDvaccination

Long COVID-19 more likely to impact women, those with anxiety and depression

As researchers take a hard look at the impacts and associations of long-haul COVID-19 infections, more trends are appearing.

First ever full course of the latest MR-guided radiation therapy treatments completed at Henry Ford Health

The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

cocaine heart failure HFrEF LVEF hospitalizations beta-blockers hypertension cardiology

How cocaine use affects outcomes for hospitalized heart failure patients

When cocaine users are hospitalized for heart failure, what should physicians expect? Are beta-blockers an effective treatment strategy?

New research compares COVID pneumonia in vaccinated vs unvaccinated patients

Even when fully vaccinated individuals contract a breakthrough COVID infection, their pneumonia frequency and severity are reduced on imaging.

The Advanta V12 and iCast (bottom image) balloon expandable covered stents were recalled by Atrium/Getinge because the balloons may not deflate quickly when using thicker contrast for endovascular use.

More than 68,000 stents recalled after multiple injuries

Dozens of customers have reported issues with the device’s balloon or catheter hub separating from the delivery system, mostly during off-label use in a patient's blood vessels.

Clinical

TAVR still a safe treatment option for immunocompromised patients

Pope welcomes cardiologists to Vatican City

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M